Prescribing trend of tapentadol in a Sydney local health district

AIMS: Tapentadol, an opioid with mu‐opioid receptor agonism and noradrenaline reuptake inhibition, has been increasingly used in Australia since 2011. However, data on hospital prescribing trends and indications are scarce. This study aimed to investigate hospital prescribing trends of tapentadol, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabella, Jennifer, Ravi, Deepa, Chiew, Angela L., Buckley, Nicholas A., Chan, Betty S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544395/
https://www.ncbi.nlm.nih.gov/pubmed/35763675
http://dx.doi.org/10.1111/bcp.15448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544395/
https://www.ncbi.nlm.nih.gov/pubmed/35763675
http://dx.doi.org/10.1111/bcp.15448

Ejemplares similares